Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Corporate Update

29 Jul 2025 07:00

RNS Number : 8890S
Versarien PLC
29 July 2025
 

 

 

29 July 2025

Versarien plc

("Versarien", the "Company" or the "Group")

Corporate Update

Versarien plc (AIM: VRS), the advanced engineering materials group, provides the following update on its restructuring process and financial position.

 

As stated in the Company's Interim Results, issued on 30 June 2025, the Board had appointed Leonard Curtis to undertake an accelerated sale of certain trade and assets of the Group's UK Technology companies (the "UK Technology Sale Process") whilst the Company focused on minimising the cash outflows from these operations. Other actions included seeking a strategic joint investment partner for the 3D Construction Printing ("3DCP") business and ceasing the trading activities of Versarien Korea Limited.

The UK Technology Sale Process has now concluded without a suitable offer being received by the Company. The Company therefore expects that Versarien Graphene Limited will shortly be placed into administration and Cambridge Graphene Limited and 2-DTech Limited will commence the process of voluntary liquidation. Versarien Korea Limited has now ceased all operations.

The ongoing Group will then consist of Versarien plc, Gnanomat SL and Total Carbide Limited (which the Company continues to market for sale) and will concentrate primarily on its hybrid nanomaterials and energy storage technologies.

These actions will conserve further cash and extend the Group's forecast runway through to the end of August 2025 to allow further time for the proposed, and previously announced, strategic investment to be closed, albeit there is no guarantee that it will do so. Should the strategic investment not be received the Board intends to appoint Leonard Curtis to conduct an accelerated sale process of the remaining Group assets.

Further announcements will be made in due course as appropriate.

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0)20 3934 6630

 

For further information please see: http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAEXPAAXSEAA
Date   Source Headline
25th Sep 20187:00 amRNSAcquisition of Gnanomat S.L.
24th Sep 20187:00 amRNSSuccessful Fundraising of £5.2m via PrimaryBid
21st Sep 20184:57 pmRNSPrimaryBid.com Offer
30th Aug 20187:00 amRNSAward of Share Options to Directors
29th Aug 20189:40 amRNSVersarien joins "Exporting is GREAT Campaign"
24th Aug 20187:00 amRNSConstruction Materials Collaboration
21st Aug 20187:00 amRNSNotice of AGM and posting of Annual Report
20th Aug 20187:00 amRNSCollaboration Agreement with AXIA Materials
15th Aug 20187:00 amRNSAppointment of further DIT secondee
2nd Aug 20187:00 amRNSSporting Goods Collaboration
31st Jul 20187:00 amRNSHolding(s) in Company
20th Jul 20187:00 amRNSGraphene Quality Assurance
19th Jul 20187:00 amRNSPreliminary Results
16th Jul 20187:00 amRNSAppointment of Head of Research
6th Jul 20187:00 amRNSNotice of Results
2nd Jul 20187:00 amRNSBattery Technology Update
25th Jun 20187:00 amRNSVersarien joins the GEIC
18th Jun 20187:00 amRNSCommercial Agreement with MediaDevil
12th Jun 20187:00 amRNSDirector/PDMR Shareholding
8th Jun 201811:00 amRNSPrice Monitoring Extension
8th Jun 20187:01 amRNSAgreement with Arrow GreenTech
8th Jun 20187:00 amRNSGraphinks Product Launch
7th Jun 20182:05 pmRNSSecond Price Monitoring Extn
7th Jun 20182:00 pmRNSPrice Monitoring Extension
7th Jun 20187:00 amRNSVersarien appointed to NGA Industry Council
29th May 20187:00 amRNSConsumer Goods Collaboration
22nd May 20187:00 amRNSAppointment of senior DIT secondee
4th May 20187:00 amRNSChange of Nominated Adviser and Broker
30th Apr 20187:00 amRNSAgreement with Luxus
16th Apr 20187:25 amRNSGraphene Supply to Major Tyre Producer
3rd Apr 20181:32 pmRNSHolding(s) in Company
28th Mar 20187:00 amRNSHexotene Product Launch
27th Mar 20187:00 amRNSCollaboration with World Leading Aerospace Group
14th Mar 20187:00 amRNSCollaboration with Team Sky
7th Mar 20181:15 pmRNSAdditional Investor Event
7th Mar 20187:00 amRNSInvestor Event
27th Feb 20184:41 pmRNSSecond Price Monitoring Extn
27th Feb 20184:35 pmRNSPrice Monitoring Extension
27th Feb 20187:00 amRNSAgreement with Vivobarefoot
21st Feb 20187:00 amRNSMedical Technology Collaboration
5th Feb 20187:00 amRNSAppointment to US National Graphene Advisory Board
2nd Feb 20184:40 pmRNSHolding(s) in Company
29th Jan 20183:18 pmRNSExercise of Options
23rd Jan 20183:33 pmRNSHolding(s) in Company
15th Jan 20182:05 pmRNSSecond Price Monitoring Extn
15th Jan 20182:00 pmRNSPrice Monitoring Extension
15th Jan 201811:05 amRNSSecond Price Monitoring Extn
15th Jan 201811:00 amRNSPrice Monitoring Extension
15th Jan 20189:05 amRNSSecond Price Monitoring Extn
15th Jan 20189:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.